Top in ID: Melioidosis in the US, COVID-19 booster dose

CDC investigators linked a fatal case of melioidosis in Georgia to three other cases of melioidosis that were reported in Kansas, Minnesota and Texas. The CDC said it suspects that an imported product is a likely source of the infections.

A report on the investigation was the top story in infectious disease last week.

Another top story was about the FDA authorization of a third COVID-19 vaccine dose for certain immunocompromised patients.

Read these and more top stories in infectious disease below:

CDC confirms fatal case of melioidosis in Georgia, links it to previous US cases

The CDC confirmed a fatal case of melioidosis in Georgia and linked it to three other cases of melioidosis in the United States, including one that was also fatal. Read more.

FDA allows third dose of COVID-19 vaccine for immunocompromised patients

The FDA authorized a third dose of COVID-19 vaccine for certain immunocompromised patients but continued to say that other fully vaccinated people do not need one. Read more.

Officials confirm first case of Marburg virus in West Africa

Health officials in Guinea have confirmed the first-ever case of Marburg virus in West Africa, WHO said. Read more.

CDC encourages pregnant women to get vaccinated against COVID-19

The CDC encouraged pregnant and breastfeeding women to get vaccinated against COVID-19 as researchers from the agency reported what they called “reassuring” data Wednesday on the safety of the vaccines. Read more.

Benefits of flu vaccine mandates partially offset by risk for other respiratory infections

Mandated influenza vaccination was associated with a decreased risk for influenza among health care personnel but an increased risk for other respiratory infections, partially offsetting the benefits of such policies, researchers reported. Read more.